Abstract Background and Aims Peritoneal Dialysis (P.D.) Adequacy includes a variety of targets such as the sufficient uremic toxins removal (Κt/V), patients’ euvolemia, acid-base electrolyte balance etc.. Based on incremental PD prescription NIPD is often reasonable modality choice when there adequate Residual Renal Function (RRF). Eventually due to RRF decrease patients need increase their ade...

Novel low-glucose degradation products (GDP) peritoneal dialysis (PD) fluids have an improved biocompatibility profile as compared to standard fluids. Clinical studies suggest that their use may be associated with favorable clinical outcomes; however, large prospective randomized studies addressing clinical endpoints such as patient and technique survival are presently lacking. Nevertheless, as...

Abstract Background and Aims Icodextrin is designed to maintain ultrafiltration during the long dwell, especially when there a risk of increased fluid reabsorption (fast peritoneal solute transfer rate, PSTR), without need for excessive use high glucose. Randomized trials have demonstrated these benefits but are insufficiently powered investigate clear impact on survival. We aimed establish int...

This study aimed to compare the increment in plasma potassium concentration ([K(+)]) as well as the role of internal K(+) balance for its changes following acute K(+) supplementation between conventional 2.5% glucose (GD) and non-glucose containing dialysate (icodextrin, ID) in continuous ambulatory peritoneal dialysis (CAPD) patients. A total of 9 stable CAPD patients (5 men and 4 women; age, ...